Andra AP fonden decreased its position in Waters Corporation (NYSE:WAT) by 20.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26,000 shares of the medical instruments supplier’s stock after selling 6,800 shares during the period. Andra AP fonden’s holdings in Waters Corporation were worth $4,780,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Fundsmith LLP increased its position in shares of Waters Corporation by 11.3% in the first quarter. Fundsmith LLP now owns 3,432,535 shares of the medical instruments supplier’s stock worth $536,540,000 after buying an additional 349,178 shares during the last quarter. TIAA CREF Investment Management LLC increased its position in shares of Waters Corporation by 42.7% in the first quarter. TIAA CREF Investment Management LLC now owns 375,413 shares of the medical instruments supplier’s stock worth $58,681,000 after buying an additional 112,335 shares during the last quarter. State Street Corp increased its position in shares of Waters Corporation by 1.7% in the first quarter. State Street Corp now owns 3,446,000 shares of the medical instruments supplier’s stock worth $538,641,000 after buying an additional 58,746 shares during the last quarter. Lowe Brockenbrough & Co. Inc. increased its position in shares of Waters Corporation by 1.1% in the first quarter. Lowe Brockenbrough & Co. Inc. now owns 1,516 shares of the medical instruments supplier’s stock worth $237,000 after buying an additional 16 shares during the last quarter. Finally, OppenheimerFunds Inc. increased its position in shares of Waters Corporation by 2.0% in the first quarter. OppenheimerFunds Inc. now owns 1,750 shares of the medical instruments supplier’s stock worth $274,000 after buying an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 91.10% of the company’s stock.

Shares of Waters Corporation (NYSE WAT) opened at 179.94 on Tuesday. Waters Corporation has a 52 week low of $133.35 and a 52 week high of $187.65. The stock has a 50 day moving average price of $179.62 and a 200-day moving average price of $170.19. The firm has a market capitalization of $14.36 billion, a PE ratio of 27.12 and a beta of 0.84.

Waters Corporation (NYSE:WAT) last released its quarterly earnings data on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.05. Waters Corporation had a net margin of 24.26% and a return on equity of 23.91%. The business had revenue of $558.30 million during the quarter, compared to analyst estimates of $553.22 million. During the same quarter in the previous year, the business earned $1.58 EPS. Waters Corporation’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities analysts anticipate that Waters Corporation will post $7.38 earnings per share for the current year.

Waters Corporation declared that its board has authorized a share buyback program on Thursday, May 11th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the medical instruments supplier to buy up to 7.3% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.watchlistnews.com/andra-ap-fonden-has-4-78-million-stake-in-waters-corporation-wat/1529451.html.

WAT has been the topic of a number of analyst reports. Zacks Investment Research downgraded Waters Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. BidaskClub downgraded Waters Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. Morgan Stanley restated an “underweight” rating and issued a $183.00 target price (up previously from $174.00) on shares of Waters Corporation in a research report on Wednesday, July 26th. Bank of America Corporation restated a “neutral” rating and issued a $192.00 target price (up previously from $180.00) on shares of Waters Corporation in a research report on Friday, July 21st. Finally, Deutsche Bank AG downgraded Waters Corporation from a “buy” rating to a “hold” rating and lifted their target price for the company from $183.00 to $194.00 in a research report on Monday, July 10th. Two analysts have rated the stock with a sell rating, five have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $186.00.

In related news, SVP Rohit Khanna sold 23,000 shares of Waters Corporation stock in a transaction on Friday, June 9th. The shares were sold at an average price of $186.90, for a total value of $4,298,700.00. Following the completion of the sale, the senior vice president now owns 27,077 shares of the company’s stock, valued at approximately $5,060,691.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Christopher A. Kuebler sold 3,500 shares of Waters Corporation stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $179.67, for a total transaction of $628,845.00. Following the completion of the sale, the director now directly owns 17,849 shares of the company’s stock, valued at approximately $3,206,929.83. The disclosure for this sale can be found here. In the last ninety days, insiders sold 40,780 shares of company stock valued at $7,545,221. 5.07% of the stock is owned by company insiders.

Waters Corporation Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.